VOQUEZNA (vonoprazan) is a potassium-competitive acid blocker (PCAB) that reduces stomach acid production. It is approved in the U.S. for adults with erosive GERD, heartburn associated with ...
The US Food and Drug Administration (FDA) approved Hovilpri (pritelivir) tablets for adults with weakened immune systems (i.e ...
Detailed analysis from the randomized, double-blind, placebo-controlled Phase 3 TRIUMpH-NERD study demonstrated that both ...
New analysis projects VOQUEZNA® (vonoprazan) to provide meaningful economic value and be cost-effective vs. proton pump inhibitors (PPIs) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results